| Boël, Harold (Sofina 202109 CEO) |
Chief Executive Officer (CEO) |
|
|
| Boeltz, Harry (Dispendix 201812 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bico (Group) |
Germany |
| Boesen, Jan (IBL International GmbH 201407 Managing Director) |
Managing Director |
Tecan (Group) |
Germany |
| Boesl-von Grafenstein, Ulrich (TU München 201007 Professor Physical Chemistry) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Boettiger, Sara (Bayer 202009– Head Crop Science Global Affairs + Science + Sustainability before McKinsey + Gates) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
Germany |
| Bogenstätter, Michael (Germany (govt) 201707 German Accelerator Life Sciences) |
n. a. |
Germany (govt) |
United States (USA) |
| Boghossian, John (Quercis Pharma 202104– CEO before VP of Operations at Compass Pathways + Boston Consulting) |
Chief Executive Officer (CEO) |
Quercis Pharma (Group) |
Switzerland |
| Bogsch, Erik (Gedeon Richter 19982– CEO joined 1970) |
Chief Executive Officer (CEO) |
Gedeon Richter (Group) |
Hungary |
| Bogsch, Erik [2] (Gedeon Richter 201405 Deputy Director Biotechnology) |
President/Director/Head Business Group/Unit/Division |
Gedeon Richter (Group) |
Hungary |
| Bohen, Sean (AstraZeneca 201509– EVP Global Medicines Developent + CMO before Genentech + Stanford Univ) |
Chief Medical Officer (CMO) |
AstraZeneca (Group) |
United Kingdom (GB) |
| Bohlen, Heribert (Axiogenesis 201603 CEO) |
Chief Executive Officer (CEO) |
Evotec (Group) |
Germany |
| Bohm, Katarina (Promega 201411 Head of Marketing at Promega GmbH) |
Sales Manager / Marketing Manager |
Promega (Group) |
Germany |
| Bohmann, Armin (Bohmann & Loosen 200809) |
n. a. |
Bohmann & Loosen (Munich) |
Germany |
| Bohn, Thomas |
n. a. |
febit (Group) |
Germany |
| Boidol, Bernhard (Bernd) (Proxygen 202012 CEO) |
Chief Executive Officer (CEO) |
Proxygen GmbH |
Austria |
| Bois, Sabine (SAW Instruments 2010– Managing Director Head Finance + co-founder) |
Managing Director |
NanoTemper (Group) |
Germany |
| Boissel, Stéphane (SparingVision 202010– CEO before Sangamo + TxCell + Genclis + Transgene + Innate Pharma + Lazard) |
Chief Executive Officer (CEO) |
SparingVision S.A.S. |
France |
| Bold, Markus (BASF 202005 Managing Director of Chemovator GmbH) |
Managing Director |
BASF (Group) |
Germany |
| Boles, Eckhard (Univ Frankfurt 201404 Professor + Head of Institute of Physiology + Genetics of Lower Eukaryotes) |
Professor |
University of Frankfurt (Goethe-Universität) |
Germany |
| Boll, Björn (Ten23 Health 202305 Senior Director for Particle Characterization + Drug Product Design) |
n. a. |
Ten23 Health AG |
Switzerland |
| Bolliger, Luca (Novimmune 201012 Director Business Development + Communication) |
Company Founder |
abcDNA GmbH |
Switzerland |
| Bollineni, Ravi Chand (Univ Leipzig 201106 Workin Group Bioanalytics) |
Researcher (university / research institute) |
University of Leipzig |
Germany |
| Bollmann, Magdolna (IMoGen GmbH 201104 Managing Director) |
Managing Director |
IMogen Institut für Molekularpathologie und Gendiagnostik GmbH |
Germany |
| Bolzon, Bradley (Brad) (Versant Ventures 200701 Managing Director) |
Managing Director |
Versant Ventures |
United States (USA) |
| Bond, Colin (Vifor Pharma 201707 CFO before Evotec 201008–201606 CFO LEFT 6/16) |
Chief Financial Officer (CFO) |
Vifor Pharma (Group) |
Switzerland |
| Bonde, Martin (Vaccibody 201508– CEO before EpiTherapeutics ApS + Aros Pharma ApS + Natimmune AS + Combio AS) |
Chief Executive Officer (CEO) |
Vaccibody AS (Euronext Growth Oslo: VACC) |
Norway |
| Bonenberger, Michael (MCH Group 201807 Exhibition Director ILMAC) |
Event Manager / Conference Manager |
MCH Group AG |
Switzerland |
| Bonert, Christian (ipOcean Global GmbH 202004 Managing Director) |
Managing Director |
ipOcean Global GmbH |
Germany |
| Bongaerts, Sabine (Bayer 201605 Head of Drug Discovery Animal Health) |
President/Director/Head Business Group/Unit/Division |
Elanco (Group) |
Germany |
| Bonham-Carter, John (Refine Technology 201201 VP Sales + Business Development) |
Sales Manager / Marketing Manager |
Refine Technology LLC |
United States (USA) |
| Bonifacio, Ezio (TU Dresden 201712 Director of CRTD) |
Professor |
Technical University Dresden (TU Dresden) |
Germany |
| Bonin, Michael (IMGM Laboratories GmbH 201408– Managing Director before Univ Tübingen Director of MFTServices) |
Managing Director |
IMGM Laboratories GmbH |
Germany |
| Bonn, Günther (Univ Innsbruck 201211 Professor + Scientific Director at ADSI) |
Professor |
University of Innsbruck |
Austria |
| Bonnet, Frank (Bionomous 202208 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bionomous S.A. |
Switzerland |
| Bonnet, Lucille (High-Tech Gründerfonds 201604 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Bonneville, Christophe (Resolution Spectra Systems 202007 President + Co-Founder) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
France |
| Bonny, Christophe (Enterome 201609– CSO before Bicycle Therapeutics + Xigen + Univ Hospital Lausanne) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Enterome S.A. |
France |
| Bonvicini, Paola (Helsinn 201705 Group Head of Communication) |
Public Relations Manager / Investor Relations Manager |
Helsinn (Group) |
Switzerland |
| Boomgaarden, Wolfgang (PharmaInformatic 200509 founder) |
n. a. |
PharmaInformatic Boomgaarden |
Germany |
| Boorsma, Marco (Forbion Capital Partners 201302) |
Partner (venture partner) |
Forbion (Group) |
Netherlands |
| Boos, Andreas (Curetis 200812– Managing Director) |
Managing Director |
OpGen (Group) |
Germany |
| Boos, Erwin (Schroders 201709 Schroder Adveq) |
Investment Manager |
Schroders (Group) |
Switzerland |
| Boosfeld, Jochen (Bruker 200809 Bruker Daltonik GmbH) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Boot, Harry (Lonza 201103–201205 COO Life Science Ingredients sector before Bluestar/Blackstone + GE) |
Chief Operating Officer (COO) |
Lonza (Group) |
Switzerland |
| Booth, Bruce (Atlas Venture 201306 Partner) |
Partner (venture partner) |
Atlas Venture (Group) |
United States (USA) |
| Booth, Mark (Probiodrug 201603–201608 CBO LEFT 8/16 before Orexigen + Takeda + Immunex + Abbott) |
Chief Business Officer (CBO) |
Vivoryon (Group) |
Germany |
| Booth, Michael (Mike) (Bit Bio 202308 SVP External Affairs before Crescendo Biologics + Incyte + Algeta + Trout Group) |
Public Relations Manager / Investor Relations Manager |
Bit Bio Ltd. (bit.bio) |
United Kingdom (GB) |
| Borchers, Christoph (Univ Victoria 200911 Facility Director UVic Proteomics Centre + MRM Proteomics 201008– CSO) |
n. a. |
University of Victoria (UVic) |
Canada |
| Borchert, Sieglinde |
n. a. |
University of Bremen |
Germany |
| Borcholte, Thomas (Wilex 200710–201312 CBO STEPPED DOWN 12/13 before TopoTarget + Biogen GmbH) |
Chief Business Officer (CBO) |
Heidelberg Pharma (Group) |
Germany |
| Borg, Agnes (EuropaBio 201809– Industrial Biotech Director) |
lobbying |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Borgas, Stefan (Lonza 200610 CEO) |
Chief Executive Officer (CEO) |
Lonza (Group) |
Switzerland |
| Borgwardt, Karsten (Max Planck 202302– Director + Head of Dept for ML + Systems Biology at MPI B before ETHZ) |
President/Director/Head of Research Organisation/Unit |
Max Planck Society for the Advancement of Science |
Germany |
| Boriss, Hinnerk (Sovicell GmbH 2007– Managing Director before Celsis International Leipzig) |
Managing Director |
Sovicell GmbH |
Germany |
| Borlak, Jürgen (Fraunhofer Institute 200106) |
n. a. |
Fraunhofer (Group) |
Germany |
| Bornmann, Gerd (ALS Automated Lab Solutions 202112 Managing Director + Co-Founder) |
Managing Director |
Sartorius (Group) |
Germany |
| Bornscheuer, Uwe T. (Univ Greifswald 201007 Professor + Co-founder Enzymicals AG) |
Professor |
University of Greifswald |
Germany |
| Borowicz, Karolina (Corning 201111 Marketing Communications Manger at HTL) |
Public Relations Manager / Investor Relations Manager |
Corning (Group) |
Poland |
| Borregaard, Saskia (CTC North 210507 Director Clinical Trial Management) |
Clinical Research Manager |
CTC North (Group) |
Germany |
| Borst, Matthias (Becton Dickinson 201102 Managing Director of Becton Dickinson GmbH) |
Managing Director |
Becton, Dickinson (Group) |
Germany |
| Borwieck, Jürgen-Heiko (Dräger 200902 Managing Director Dräger Medical Deutschland GmbH) |
Managing Director |
Dräger (Group) |
Germany |
| Bos, Harry (Sanguin Blood Supply 201409 Director of Diagnostics) |
n. a. |
Sanquin (Group) |
Netherlands |
| Bos, Jasper (Forbion 202105 General Partner before M Ventures + Netherlands Vaccine Institute) |
General Partner (venture partner) |
Forbion (Group) |
Netherlands |
| Bosc, Jessica (JSR Corp 201903– Director Business Development + Licensing for Selexis in Boston) |
Business Development Manager / Strategy Manager |
JSR Corporation (Group) |
United States (USA) |
| Boshoff, Chris (Pfizer 201610 Head of Immuno-Oncology, Early Developm + Translational Oncology) |
Research & Development Manager |
Pfizer (Group) |
United States (USA) |
| Bosio, Andreas (Miltenyi Biotec 202007 Senior RnD Manager) |
Research & Development Manager |
Miltenyi Biotec (Group) |
Germany |
| Bosisio, Lorenzo (EffRx Pharmaceuticals 201607– CEO before CCO since 2013 before Amgen + Alexion + PwC + Tissot Medical) |
Chief Executive Officer (CEO) |
EffRx Pharmaceuticals S.A. |
Switzerland |
| Bosker, Gideon (DarwinHealth 201811 CEO) |
Chief Executive Officer (CEO) |
DarwinHealth (US) |
United States (USA) |
| Boss, Christopher (NürnbergMesse 202108 Director of MEdtecLIVE) |
Product Manager (personnel) |
NürnbergMesse GmbH (Messe Nürnberg) |
Germany |
| Bossert, Michael (Enamine Ltd 201201 Business Development Director) |
Business Development Manager / Strategy Manager |
Enamine Ltd. (UA) |
Ukraine |
| Bossko, Andreas (Axolabs 201603 Managing Director (CFO) before Roche Kulmbach + Ribopharma) |
Managing Director |
LGC (Group) |
Germany |
| Bosslet, Klaus (Roche 201309 Head of Roche Discovery Oncology in Penzberg) |
Research & Development Manager |
Roche (Group) |
Germany |
| Bosson, Oskar (Swedish Orphan Biovitrum 201512 Head of Communications) |
Public Relations Manager / Investor Relations Manager |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Bott, Martin (BioVersys 202105– CFO before AMR Action Fund + Eli Lilly) |
Chief Financial Officer (CFO) |
BioVersys AG |
Switzerland |
| Botti, Paolo (Arisgen 2007) |
n. a. |
ArisGen S.A. |
Switzerland |
| Botti, Simone (Inkef Capital 202104 Junior Partner before Metabomed + MS Ventures Israel Bioincubator Fund) |
Partner (venture partner) |
ABP (Stichting Pensioenfonds) (Group) |
Netherlands |
| Botzler, Claus (Numares 202006 CBO) |
Chief Business Officer (CBO) |
Numares (Group) |
Germany |
| Bouchon, Axel (ARCH Venture 202112– Venture Partner + BrainGames before Leaps by Bayer + Moderna Therapeutics) |
Venture Partner |
ARCH Venture (Group) |
United States (USA) |
| Bouet, Laurence (Innopsys 201303 Executive + Sales Director) |
Sales Manager / Marketing Manager |
Innopsys (Group) |
France |
| Boulais Raveneau, Amélie (Sartorius 201803 Vaccine Platform Marketing Manager at SSB) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
France |
| Boulanger, Dimitri (Céleste Management 202012 CEO) |
Chief Executive Officer (CEO) |
Céleste Management S.A. |
Switzerland |
| Boulnois, Graham (SV Life Sciences 201105 Senior Partner) |
Partner (venture partner) |
SV Health Investors (Group) |
United Kingdom (GB) |
| Boulud, Pierre (Mérieux 202310 CEO of bioMèrieux joined 11/16 before Ipsen + Boston Consulting + Bossard Consultants) |
Chief Executive Officer (CEO) |
Mérieux (Group) |
France |
| Bourdon, Christophe (Leo Pharma 202204– CEO before Orphazyme + Amgen + Alexion) |
Managing Director |
Leo Pharma (Group) |
Denmark |
| Bourla, Albert (Pfizer201605 Group President Global Innovative Pharma + Vaccines, Oncology + Consumer Healthcare) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
| Boury, Guillaume (Telos Impact 202309 Investment Manager) |
Investment Manager |
Telos Impact |
|
| Bout, Bram (ProFibrix BV 200703– CTO before Crucell VP Protein Production) |
Research & Development Manager |
Novartis (Group) |
Netherlands |
| Bouterfa, Hakim (Eckert & Ziegler 202306 CMO formerly Managing Director of OctreoPharm Sciences GmbH) |
Chief Medical Officer (CMO) |
Ipsen (Group) |
Germany |
| Bouvier, Frédéric (Minapharm 202211 Head Corp Development, BusDev + Licensing at MiGenTra) |
Business Development Manager / Strategy Manager |
Minapharm (Group) |
Germany |
| Boven, Karl-Heinz (Multi Channel Systems MCS Founder) |
Company Founder |
Harvard Bioscience (Group) |
Germany |
| Boxheimer, Carmen (Danaher 201709 Sciex) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Germany |
| Boyce, John (BrickBio 202009 CEO + CO-Founder of TigeGene formerly Exosome Diagnostics 201806 CEO) |
Chief Executive Officer (CEO) |
TigerGene LLC |
United States (USA) |
| Boyle, Robert (Sentinel Oncology 201605 CEO) |
Chief Executive Officer (CEO) |
Sentinel Oncology Ltd. |
United Kingdom (GB) |
| Bozicevic, Falko (GoingPublic Media 200902 Editor) |
Editor / Publisher |
GoingPublic Media AG (FSE: WKN 761 210) |
Germany |
| Bozotti, Carlo (STMicroelectronics 200702 Pres + CEO) |
Chief Executive Officer (CEO) |
STMicroelectronics (Group) |
Switzerland |
| Braam, Stefan (Ncardia 201709– CEO before Pluriomics) |
Chief Executive Officer (CEO) |
Kiniciti Bio (WCAS invesment platform) (Group) |
Belgium |
| Brabeck-Letmathe, Peter (Nestlé –200711– Chairman + CEO) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
Switzerland |
| Bracco, Fulvio Renoldi (Bracco 201710 CEO at Bracco Imaging SpA) |
Chief Executive Officer (CEO) |
Bracco (Group) |
Italy |
| Bracht, Franzpeter (Celonic 201711– COO before Glycotope + Aplagen + Ernst & Young + Kienbaum) |
Chief Financial Officer (CFO) |
Celonic (Group) |
Switzerland |
| Bradley, Denise (Roche 202310 Communications at Spark Therapeutics) |
Public Relations Manager / Investor Relations Manager |
Roche (Group) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 7 8 9 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
